Sennales-Ruseuro (Tablets) Instructions for Use
Marketing Authorization Holder
Nabros Pharma, Pvt. Ltd. (India)
ATC Code
A06AB06 (Sennosides A and B)
Active Substance
Sennosides A and B (Grouping name)
Dosage Form
| Sennales-Ruseuro | Tablets 13.5 mg: 60 pcs. |
Dosage Form, Packaging, and Composition
Tablets are round, flat, with beveled edges and a score on one side, brown in color, with the presence of inclusions of a darker color allowed.
| 1 tab. | |
| Senna leaf dry extract (as the sum of calcium salts of sennosides A and B calculated as sennoside B) | 13.5 mg |
Excipients: sodium carboxymethyl starch, starch, colloidal silicon dioxide, croscarmellose, lactose, talc.
20 pcs. – blisters (3) – cardboard packs.
Clinical-Pharmacological Group
Laxative drug that stimulates intestinal peristalsis
Pharmacotherapeutic Group
Laxative of plant origin
Pharmacological Action
A laxative of plant origin. It has a laxative effect that occurs after 8-10 hours. The laxative effect is due to the effect on the receptors of the large intestine, which enhances peristalsis.
Indications
Constipation caused by hypotension and sluggish peristalsis of the large intestine; regulation of stool in hemorrhoids, proctitis, anal fissures.
ICD codes
| ICD-10 code | Indication |
| K59.0 | Constipation |
| ICD-11 code | Indication |
| DB32.1 | Slow-transit constipation |
| DD91.1 | Functional constipation |
| DE2Z | Diseases of the digestive system, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take orally, typically as a single daily dose in the evening before bedtime.
Swallow the tablet whole with a sufficient amount of water.
For adults and children 12 years and older, the usual dose is 1-2 tablets (13.5-27 mg).
For children 6 to 11 years old, the usual dose is 1 tablet (13.5 mg).
Do not exceed the maximum daily dose of 4 tablets (54 mg).
Adjust the dose individually to achieve soft stool; use the lowest effective dose.
The laxative effect usually occurs within 8-10 hours after administration.
Limit use for short-term treatment; do not use continuously for more than 2 weeks without medical consultation.
If constipation persists or you need to use a laxative regularly, consult a doctor to determine the underlying cause.
Adverse Reactions
From the digestive system: cramping abdominal pain, flatulence are possible; with long-term use, especially in high doses, melanin deposition in the intestinal mucosa, nausea, vomiting, diarrhea are possible.
From the metabolism: with long-term use, especially in high doses, disturbances in water-electrolyte balance, melanin deposition in the intestinal mucosa are possible.
From the urinary system: with long-term use, especially in high doses, albuminuria, hematuria, discoloration of urine are possible.
From the nervous system: with long-term use, especially in high doses, convulsions, fatigue, confusion are possible.
Dermatological reactions: with long-term use, especially in high doses, skin rash is possible.
From the cardiovascular system: with long-term use, especially in high doses, vascular collapse is possible.
Contraindications
Hypersensitivity to the active substance, spastic constipation, intestinal obstruction, abdominal pain of unclear origin, strangulated hernia, acute inflammatory diseases of the abdominal cavity, peritonitis, gastrointestinal and uterine bleeding, cystitis, disturbances of water-electrolyte balance; children under 6 years of age.
With caution
Liver and/or kidney diseases, pregnancy, breastfeeding period, conditions after abdominal surgery.
Use in Pregnancy and Lactation
Use with caution during pregnancy and breastfeeding.
Use in Hepatic Impairment
Use with caution in liver diseases.
Use in Renal Impairment
Use with caution in kidney diseases.
Pediatric Use
Contraindicated for use in children under 6 years of age.
Geriatric Use
The drug is approved for use in elderly patients.
Special Precautions
It is not recommended to use this remedy for more than 2 weeks.
After administration, urine may turn yellow-brown or red-lilac in color.
Drug Interactions
With long-term use in high doses, an enhancement of the effect of cardiac glycosides and an influence on the effect of antiarrhythmic drugs is possible due to the potential development of hypokalemia.
With simultaneous use with thiazide diuretics, corticosteroids, licorice root preparations, the risk of developing hypokalemia increases.
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer
Kagocel pills 12mg, 30pcs
Cortexin, 10mg, 5ml, 10pcs
Actovegin pills 200mg, 50pcs
Nootropil pills 800mg, 30pcs
Ingavirin capsules 90mg, 10pcs
Noopept, pills 10mg, 50pcs
No-spa pills 40mg, 64pcs
Belosalic, ointment, 30g
Belosalic, lotion solution for external use spray 100ml
Cerebrolysin, solution for injection 2ml ampoules 10pcs
Phenibut-Vertex pills 250mg, 20pcs
Mildronate capsules 500mg, 90pcs
Fenotropil pills 100mg, 60pcs
Arbidol, capsules 100mg, 40pcs
Daivobet, ointment, 30g
OKI, sachets 80mg 2g, 12pcs
Picamilon pills 50mg, 60pcs 